(Q38887874)

7 September 2017

title

Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? (English)

1 reference

7 September 2017

0 references

0 references

1 reference

2

Bengt Winblad

1 reference

7 September 2017

Fabrizio Piazza

1

1 reference

7 September 2017

publication date

29 March 2016

1 reference

Journal of Alzheimer's Disease

7 September 2017

published in

1 reference

7 September 2017

volume

52

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

417-420

1 reference

MR imaging features of amyloid-related imaging abnormalities.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160122

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160122

Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160122

Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160122

Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160122

Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160122

Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160122

21 January 2018

Identifiers

DOI

10.3233/JAD-160122

1 reference

7 September 2017

1 reference